Clinical trial results indicate that a fixed-dose combination of dapagliflozin, glimepiride, and metformin offers superior glycemic control in diabetes therapy.
A three-drug diabetes pill outperformed dual therapy
- Post author:admin
- Post published:
- Post category:uncategorized
- Post comments:0 Comments